Hyperlane launched its airdrop eligibility checker, allowing users to verify if their wallets qualify for the upcoming ...

Variant SAS and the Rare Ocular Diseases Center at the University of Campania Luigi Vanvitelli (UCLV) have received positive feedback from the EMA for VAR-002, a recombinant AAV vector gene therapy ...

Beigene Ltd. said it is shutting down development of its anti-TIGIT antibody, ociperlimab (BGB-A1217), after the humanized IgG1-variant monoclonal antibody failed a phase III trial in lung cancer. The ...

As with the rugged PV5 and EV9 concepts from SEMA 2025, the Tasman Weekender adds a dose of personality with lime green ...

Variant, a company dedicated to developing innovative treatments for orphan inherited eye diseases, and the Rare Ocular Diseases Center at the University of Campania Luigi Vanvitelli (UCLV) in Naples ...

We now know what Samsung's intentions for the Galaxy S25 Edge European prices were... before reportedly moving the ultra-thin ...

The Polestar 2 electric hatchback has been given a 2026 model year revamp, complete with more range and latest technology.

A top Apple exec says the 2025 iPhone launch will be its 'most ambitious' to date. With 15+ years of covering the iPhone ...

Google has pushed out a shiny new AI model in the form of Gemini 2.5 Pro—and it's available for free. As with many recent AI ...

AIRNA’s lead candidate AIR-001 works by correcting the most common pathologic mutation driving the rare disease alpha-1 ...

Pharma presented results showing statistically significant improvements in clinical outcomes as compared to placebo for time ...

Lilly said it is planning to request a re-examination of the CHMP's appraisal of Kisunla, pointing out that the drug has ...